awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34593276-02C22E2A-CA6E-4EC1-9EB3-EB4BCE817DE5
Q34593276-02C22E2A-CA6E-4EC1-9EB3-EB4BCE817DE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34593276-02C22E2A-CA6E-4EC1-9EB3-EB4BCE817DE5
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study
P50
Q34593276-02C22E2A-CA6E-4EC1-9EB3-EB4BCE817DE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34593276-02C22E2A-CA6E-4EC1-9EB3-EB4BCE817DE5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c458e9f645fdfac6babe935b2c1b151db8a6206c
P1545
2
http://www.w3.org/2001/XMLSchema#string
P1932
Kati Maharry
http://www.w3.org/2001/XMLSchema#string
P50
Kati Maharry